Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 19, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Erez Raphael, Chief Executive Officer, is scheduled to participate and host...
Jan 27, 2021Expands DarioHealth's multi-condition platform into the $213 billion musculoskeletal market and creates one of the most comprehensive digital health platformsDarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the signing of a definitive agreement to acquire digital musculoskeletal (MSK) company...
-
Jan 21, 2021Digital health executive Chris Chan held prior roles at Mercer, Willis Towers Watson, and SleepQuest
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. Mr. Chan will...
-
Jan 13, 2021Dr. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Dr. Marilyn Ritholz and Dr. David Horwitz will join Chairman Eric Milledge on its...
- Jan 7, 2021Prior senior management roles at Omada Health, American Well, AIG, United Healthcare, and Humana
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Claudia Rimerman Kraut as Vice President of Broker and Consultant...
- Jan 5, 2021Partnership with Vitality Group activates Dario's penetration into the self-insured employer market.
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its digital therapeutics...
- Dec 22, 2020Agreement expands Dario's provider-centric RPM offering to one of the largest integrated healthcare systems in New Mexico
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its remote patient monitoring...
- Nov 24, 2020Dario's top-rated digital diabetes tools and coaching will be available to eligible employees and their dependents starting January 1, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today that it has signed a contract to provide its digital therapeutics solution to eligible...
- Nov 19, 2020- 20th Annual Diabetes Technology Society meeting presentation documents outcomes in Dario study of 940 members
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, presented results from a new clinical study of 940 members at the 20th Annual Diabetes Technology Society...
- Nov 12, 2020Ramp up of U.S. commercial sales and marketing infrastructure resulting in B2B2C pipeline growth
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter 2020 and provided a corporate and commercial update....
-
Nov 4, 2020Earnings Discussion and Business Update Scheduled for 9:00 am Eastern Time
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it would release its second quarter ended September 30, 2020,...
- Oct 13, 2020DarioHealth selected after careful vetting of numerous digital therapeutics providers.
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that Vitality Group has chosen the company's digital therapeutics solutions for inclusion in...
- Sep 21, 2020Agreement extends DarioHealth's reach into HMC's vast multi-employer welfare fund and employer client base through which HMC is currently managing more than one million members
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, and HMC HealthWorks, a 40-year veteran in healthcare management with clinically-integrated models of care...
-
Sep 16, 202040+ year healthcare career includes serving as Company Group Chairman at LifeScan, Inc., a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ)
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company's newly-established...
-
Aug 13, 2020Observational study results demonstrate improved blood pressure and glycemic control for patients suffering from hypertensive blood pressure and diabetes who used the Dario platform
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual...
- Aug 12, 2020Advanced discussions with health plans and self-insured employers furthering our transformation to a B2B2C digital therapeutics leader
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter 2020 and provided a corporate and commercial update....
- Aug 7, 2020Earnings Discussion and Business Update Scheduled for 9:00 am Eastern Time
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial...
-
Jul 31, 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including...
-
Jul 20, 2020DarioHealth Enters UK Remote Patient Monitoring (RPM) Market Through Agreement with Williams MedicalAgreement makes the DarioHealth RPM solution available to chronic care patients at general practices across the UK and Ireland
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that the company has entered into a new strategic partnership with Williams Medical to make the...
-
Jul 6, 2020Addition adds nearly 30 years of senior health plan leadership expertise to the company's Board
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has appointed veteran health plan executive Dennis A. Matheis to its Board...
- Jun 18, 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management...
- Jun 17, 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that Omar Manejwala, M.D., Chief Medical Officer, will present at the virtual Going Digital:...
- Jun 15, 2020Demonstrated a eA1c reduction of 1.42% which was sustained for two years
DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) company, presented the results of two new studies at the American Diabetes Association's (ADA) 80th Scientific...
- Jun 11, 2020Leverages Dario's flexible AI-driven platform to facilitate rapid implementation and potential revenue in 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has signed its first two remote patient monitoring (RPM) agreements. Remote...
- May 12, 2020Continued transformation to a software as a service (SaaS)-based membership model with recurring revenues and higher margin profile
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter 2020 and provided a corporate and commercial update....
-
May 6, 2020
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings,...
- May 5, 2020Earnings Discussion and Business Update Scheduled for 8:30 am Eastern Time
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its first quarter ended March 31, 2020 financial...
-
May 4, 2020
DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include...
- Apr 29, 2020Partnership with global telemedicine leader MediOrbis creates a social distancing compliant, complete care Dario solution
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in global digital therapeutics (DTx), announced today a new partnership with value-based telemedicine provider MediOrbis to expand Dario's existing...
-
Mar 26, 2020Chief Medical Officer and Head of Managed Markets to Report directly to Rick Anderson, President & General Manager North America
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Omar Manejwala, M.D to the newly created position of Chief Medical...
- Mar 25, 2020DarioHealth® Receives Endorsement from the Organization for the Review of Care & Health Applications (ORCHA)
DarioHealth Corp. (NASDAQ: DRIO), a global digital therapeutics (DTx) innovator, announced today an endorsement from the U.K. based ORCHA, highlighting the Company's Diabetes Management...
- Mar 24, 2020
DarioHealth Corp. (Nasdaq: DRIO) ("Dario") a pioneer in the global digital therapeutics market, announced today that it has entered into a partnership with Vitality Group, a global health and...
- Mar 17, 2020
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a...
-
Mar 12, 2020Earnings Discussion and Business Update Scheduled for 8:30 am EDT
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its fourth quarter and year end 2019 results on Tuesday, March 17, and host a...
- Mar 5, 2020Yadin Shemmer & Adam K. Stern to serve until the 2020 Annual Meeting of Stockholders
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the company has appointed Yadin Shemmer and Adam K. Stern to serve as board members effective...
-
Feb 24, 2020
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as...
- Feb 19, 2020Patients Significantly Reduced Hypoglycemic and High Glycemic Events by 50% and 40%, respectively, over a Two-Year Period
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a pioneer in the global digital therapeutics market, today presented a new clinical study at the Advanced Technologies & Treatments for...
-
Jan 31, 2020
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that on January 30, 2020, Richard Anderson was granted a...
-
Jan 9, 2020Expertise Sharpens Dario's Focus on Execution and Expansion within the U.S. B2B Channel
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today the appointment of Richard Anderson as its President and...
-
Dec 20, 2019
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that it has closed on a private placement of convertible...
-
Dec 3, 2019DarioHealth Expands Retail Distribution Through Walmart.com
Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Walmart is the largest...
- Nov 25, 2019Dario Expands Membership Offering to a New Channel where Retailers are Visited by Millions of Consumers Each Year
Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), announced today that its online membership offering will now be available for purchase...
-
Nov 15, 2019- Based on data collected from active users, Dario proves digital interventions can play a key role in management of chronic conditions like diabetes
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting...
- Nov 14, 2019- DarioHealth CEO Joins Digital Health Industry Innovators panel in discussion on the need for clinical evidence
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Dario's CEO, Erez Raphael, will be participating in a panel...
- Nov 12, 2019Action Urgent Care Selects DarioHealth's Blood Glucose Monitoring System™ to Extend Its Existing Digital Health Offering
Global digital therapeutics innovation leader, DarioHealth Corp. (NASDAQ: DRIO) announced today the launch of a Dario-powered digital diabetes program with Action Urgent Care. Action Urgent Care...
-
Oct 28, 2019
Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported financial and operational results for the third quarter ended September 30, 2019. Q3 2019 Revenues of $1.87...
-
Oct 22, 2019
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, has appointed Dr. Abigail Hirsch to its Advisory Board where she will help guide...
-
Oct 17, 2019Earnings Discussion and Business Update Scheduled for 9:00 am EDT
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its third quarter 2019 results on Monday, October 28, and host a conference call the...
-
Sep 23, 2019- Panel titled "Digital Therapeutics Deliver Evidence-based Results: The Example of DarioHealth"
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth's Chief Executive Officer, will be a...